Oct 4 (Reuters) -
* HHS sponsors commercial manufacturing tests for Ebola vaccine
* HHS says contract could be extended for up to a total of five years and $75.98 million to support additional safety studies
* HHS says ebola vaccine will take next critical steps in development under $24.8 million contract between U.S. HHS and BioProtection systems
Our Standards: The Thomson Reuters Trust Principles.